How small proteins called chemokines could be the answer to getting cancer-busting CAR-T cells directly into solid tumours - Carina Biotech

Figure 1. CAR-T cells versus the solid tumor microenvironment (from Foeng et al 2022). ____________ It is now no secret that chimeric antigen receptor (CAR)-T cell therapy has produced remarkable […]

Surpassing CAR-T, CAR-M drives the solid tumor treatment forward - ACROBiosystems

Leanna Read on LinkedIn: How small proteins called chemokines could be the answer to getting…

Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer - ScienceDirect

Guidelines for the use of flow cytometry and cell sorting in immunological studies* - Cossarizza - 2017 - European Journal of Immunology - Wiley Online Library

Cancers July-1 2022 - Browse Articles

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity - ScienceDirect

IJMS September-2 2023 - Browse Articles

Kathy Sharrard, Author at Carina Biotech

Luciferase Reporter Cancer Cell Lines Facilitate CAR-T Development

Frontiers Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers

CAR T Cells - The Definitive Guide

Purines 2018 Basic and Translational Science on Purinergic Signaling and its Components for a Healthy and Better World

Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. - Abstract - Europe PMC

The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth - ScienceDirect